Home/Filings/4/0001601485-21-000058
4//SEC Filing

Neylan John F. 4

Accession 0001601485-21-000058

CIK 0001601485other

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 4:32 PM ET

Size

5.1 KB

Accession

0001601485-21-000058

Insider Transaction Report

Form 4
Period: 2021-09-20
Neylan John F.
See Remarks
Transactions
  • Sale

    Common Stock

    2021-09-20$10.07/sh376$3,78636,241 total
Footnotes (2)
  • [F1]The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.09 inclusive.

Issuer

Angion Biomedica Corp.

CIK 0001601485

Entity typeother

Related Parties

1
  • filerCIK 0001640447

Filing Metadata

Form type
4
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:32 PM ET
Size
5.1 KB